One study proposed a mechanism for the underlying efficacy for SGBs in CRPS and PTSD, which involved the increased release of NGF in pathological states, leading to an increase in Norepinephrine and sympathetic hyperactivity. This evidence concerns the gene NGF and complex regional pain syndrome.